Search results
Marcea Bland Lloyd, J.D., serves as chair of the nominating and governance committee and has more than 40 years of executive management, operational and legal experience, predominantly in healthcare.
Marcea Bland Lloyd, J.D., has more than 40 years of executive management, operational and legal experience, predominantly in healthcare. She served as chief administrative officer and general counsel of Amylin Pharmaceuticals, prior to the company’s acquisition by Bristol-Myers Squibb.
Marcea Bland Lloyd is Former Senior VP/CAO/General Counsel at Amylin Pharmaceuticals Inc. See Marcea Bland Lloyd's compensation, career history, education, & memberships.
- Former Senior VP/CAO/General Counsel
- Amylin Pharmaceuticals Inc
May 30, 2024 · Marcea Bland Lloyd is an Independent Director at Poseida Therapeutics, Inc. She previously served as Chairman at Executive Leadership Foundation, Inc. and Director at California Healthcare Institute. Marcea also held the position of General Counsel, SVP-Legal & Corporate Affairs at Amylin Pharmaceuticals, Inc. from 2007 to 2011.
We are a clinical-stage biopharmaceutical company leveraging our proprietary non-viral gene engineering technologies to create ground-breaking, life-saving cell and gene therapies.
Sep 13, 2011 · September 13, 2011 -- Marcea Bland Lloyd, one of Amylin’s executive officers, was promoted to the role of Senior Vice President, Chief Administrative Officer (CAO) and General Counsel.
Feb 7, 2007 · SAN DIEGO, Feb. 6 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. today announced that Marcea Bland Lloyd has been appointed Senior Vice President, Legal and Corporate Affairs, and General Counsel.
